KEMRI destroys its stockpiles of Polio viruses
Acting Director KEMRI, Dr. Gerald Mkoji addressing the press flunked on his right by the Head of Disease Surveillance and Response Dr. Daniel Langat and the WHO Coordinator of Polio Eradication for the Horn of Africa, Dr. Sam Okiror shortly before destroying the polio subtype 2 virus at the Institute yesterday.
Switzerland seeks more collaboration with KEMRI Scientists
Ambassador, Mauro Moruzzi, the head of International Affairs at the Swiss State Secretariat for Education, Research and Innovation is briefed by the Acting Director, KEMRI, Dr. Gerald Mkoji. Amb. Moruzzi lead a delegation of 15 researchers and academicians in a tour of the Institute on Thursday, 14th, January, 2016.
THE 2nd KEMRI ANNUAL SCIENTIFIC AND HEALTH (KASH) CONFERENCE, FEBRUARY 8-10, 2012, KEMRI HEADQUARTERS, NAIROBI, KENYA
CALL FOR ABSTRACTS
Last year, KEMRI hosted the 1st KEMRI Annual Scientific and Health (KASH) Conference on:Â Advances in health research towards Kenya Vision 2030. The 2nd KASH Conference will be held from 8th to 10th February, 2012 at KEMRI Headquarters in NAIROBI, KENYA under the theme Towards a healthy, globally competitive nation: Vision 2030 flagships. The conference will focus on the promotion of Critical Knowledge, skills, entrepreneurship for Competitiveness. You are all invited to submit Abstracts. Deadline for submission of Abstracts is 30th November 2011. Details for the preparation and submission of Abstracts are provided below.
Pre-conference symposiums shall be held on 7th February 2012 to address: 1) Road Traffic Accidents: Epidemiology, Socio-economic impact, mitigating factors; 2) Non-communicable Diseases; 3) Knowledge Translation and Knowledge Management- REACH-PI
Who should attend
Abstracts Preparation and Submission: Abstracts for consideration as oral or poster presentations must be prepared in English, using Tahoma typeface size 12, in single line spacing. Abstract title (with the text center justified) should include the title, author's names and affiliations (list multiple affiliations one below the other) and mark each with a superscript. The name of the corresponding author, where there is more than one author, should be marked with an asterisk superscript (*), and E-mail, telephone/Fax contacts of the corresponding author provided as a footnote. The Abstract body should be no more than 350 words, should contain 3-6 keywords, and should be divided into sub-sections as follows:
Language and Submission Policy: The abstract should be prepared in grammatically correct English, well structured, and in easy to understand language. First authors are limited to a maximum of two oral presentations.
Mode of Presentations: Presentations are welcome in oral and poster formats. Posters should have a uniform size of A0 and legible. Audio-visual equipment (lap top computers and LCD projectors) will be available for oral presentations at the Conference venue.
Abstracts Acceptance: The Conference Scientific Committee reserves the right to accept or reject an Abstract. Authors of accepted Abstracts will be required to submit full papers to be peer-reviewed for publication in the African Journal Health Sciences.
Exhibitions/Promotions: Companies/Organizations are most welcome to display promotional items at the Exhibition stands provided at a fee of KShs80,000.00 for the three days of the meeting.
Conference Registration Fee: Early Registration Fee (before 16th January 2012) KShs1,000, Late Registration (after 16th January 2012) KSH 2,000.
Early registration payment can be made to the following bank account
Kenya Medical Research Institute
Kenya Commerial Bank
US Defense Threat Reduction Agency (DTRA) Director visits KEMRI
The Director of the United States Department of Defense, Defense Threat Reduction Agency (DTRA),Dr. Elizabeth S. George,(seated,fourth from right) poses for a group photograph with KEMRI staff led by Deputy Director in charge of Research & Development ,Prof. Elizabeth Bukusi (seated, fourth from left) when she visited KEMRI on Monday, 25th, January, 2016.
DTRA director who was accompanied by other officials from the agency pledged to continue supporting the Institute to improve its levels of preparedness and reduction of any threat emanating from its work.
Headquartered in Fort Belvoir, Virginia in the US, DTRA's main functions are threat reduction, threat control, combat support, and technology development. Prof. Bukusi represented, Acting Director, KEMRI, Dr. Gerald Mkoji at the function.